Martin Eugene Tanner
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Martin Eugene Tanner has a total of 86 co-authors. Here are the top co-authors by number of shared publications:
- Antonina Roll-Mecak
Cell Biology and Biophysics Unit, National Institute of Neurological Disorders and Stroke
5 shared publications Yanjie Liu
Department of Chemistry, University of British Columbia, Vancouver, Canada
5 shared publicationsArvind S. Soni
Department of Chemistry, University of British Columbia, Vancouver, Canada
4 shared publications- Chang Sheng-Huei Lin
Institute of Molecular Biology, Academia Sinica, Taipei, Taiwan, ROC
3 shared publications Condurache M. Vacariu
Department of Chemistry, University of British Columbia, Vancouver, Canada
3 shared publications- Michael E. P. Murphy
Department of Microbiology and Immunology, University of British Columbia, Vancouver, BC, Canada V6T 1Z3
3 shared publications
Latest Publications
- Open Access
- 6 October 2026
- Published by Wiley in Chemistry – A European Journal
MurNAc‐Based Electrophilic Inhibitors of O ‐Acetylpeptidoglycan Esterase (Ape): Design, Synthesis, and Kinetic Evaluation
Peptidoglycan (PG) is the key structural component of the bacterial cell wall, responsible for cellular shape and structural integrity. Postsynthetic modifications to PG enable bacteria to evade innate immunity and regulate endogenous autolysins. Among these, C‐6 O ‐acetylation protects PG from lysozyme degradation, while O ‐acetylpeptidoglycan esterase (Ape) removes this modification to restore the free C‐6 hydroxyl group required for lytic transglycosylase activity. Deletion of the ape gene resulted in aberrant cell morphology and attenuated virulence, identifying Ape as a potential antibacterial target. Previously, we reported aldehyde‐based competitive inhibitors ( K i = 13 µM) of Ape from Campylobacter jejuni and demonstrated that formation of a covalent hemiacetal adduct, which mimics the tetrahedral intermediate in catalysis, is critical for binding. In this work, we expanded the inhibitor series to examine the contributions of the peptide stem, the anomeric substituent, and the electrophilic carbonyl functionality to Ape inhibition. The synthesized reversible competitive inhibitors exhibited micromolar to submillimolar potency. Peptide stem extension provided little improvement in affinity, while a benzyl substituent at the anomeric position reduced inhibitory potency. Monofluorinated analogues showed modest improvements, whereas difluoroaldehyde and trifluoromethyl ketone derivatives displayed reduced affinity. Finally, irreversible covalent inhibitors bearing dimethylphosphonate and epoxide functionalities proved ineffective against Ape.
- 6 October 2026
- Published by Wiley in Chemistry – A European Journal
Open AccessMurNAc‐Based Electrophilic Inhibitors of O ‐Acetylpeptidoglycan Esterase (Ape): Design, Synthesis, and Kinetic Evaluation
Peptidoglycan (PG) is the key structural component of the bacterial cell wall, responsible for cellular shape and structural integrity. Postsynthetic modifications to PG enable bacteria to evade innate immunity and regulate endogenous autolysins. Among these, C‐6 O ‐acetylation protects PG from lysozyme degradation, while O ‐acetylpeptidoglycan esterase (Ape) removes this modification to restore the free C‐6 hydroxyl group required for lytic transglycosylase activity. Deletion of the ape gene resulted in aberrant cell morphology and attenuated virulence, identifying Ape as a potential antibacterial target. Previously, we reported aldehyde‐based competitive inhibitors ( K i = 13 µM) of Ape from Campylobacter jejuni and demonstrated that formation of a covalent hemiacetal adduct, which mimics the tetrahedral intermediate in catalysis, is critical for binding. In this work, we expanded the inhibitor series to examine the contributions of the peptide stem, the anomeric substituent, and the electrophilic carbonyl functionality to Ape inhibition. The synthesized reversible competitive inhibitors exhibited micromolar to submillimolar potency. Peptide stem extension provided little improvement in affinity, while a benzyl substituent at the anomeric position reduced inhibitory potency. Monofluorinated analogues showed modest improvements, whereas difluoroaldehyde and trifluoromethyl ketone derivatives displayed reduced affinity. Finally, irreversible covalent inhibitors bearing dimethylphosphonate and epoxide functionalities proved ineffective against Ape.
- Open Access
- 16 November 2024
- Published by Springer Nature in Nature Communications
- Vol. 15 (1) , 1-16
Cryo-EM characterization of the anydromuropeptide permease AmpG central to bacterial fitness and β-lactam antibiotic resistance
Bacteria invest significant resources into the continuous creation and tailoring of their essential protective peptidoglycan (PG) cell wall. Several soluble PG biosynthesis products in the periplasm are transported to the cytosol for recycling, leading to enhanced bacterial fitness. GlcNAc-1,6-anhydroMurNAc and peptide variants are transported by the essential major facilitator superfamily importer AmpG in Gram-negative pathogens including Escherichia coli, Klebsiella pneumoniae, Acinetobacter baumannii, and Pseudomonas aeruginosa. Accumulation of GlcNAc-1,6-anhydroMurNAc-pentapeptides also results from β-lactam antibiotic induced cell wall damage. In some species, these products upregulate the β-lactamase AmpC, which hydrolyzes β-lactams to allow for bacterial survival and drug-resistant infections. Here, we have used cryo-electron microscopy and chemical synthesis of substrates in an integrated structural, biochemical, and cellular analysis of AmpG. We show how AmpG accommodates the large GlcNAc-1,6-anhydroMurNAc peptides, including a unique hydrophobic vestibule to the substrate binding cavity, and characterize residues involved in binding that inform the mechanism of proton-mediated transport.
- 16 November 2024
- Published by Springer Nature in Nature Communications
- Vol. 15 (1) , 1-16
Open AccessCryo-EM characterization of the anydromuropeptide permease AmpG central to bacterial fitness and β-lactam antibiotic resistance
Bacteria invest significant resources into the continuous creation and tailoring of their essential protective peptidoglycan (PG) cell wall. Several soluble PG biosynthesis products in the periplasm are transported to the cytosol for recycling, leading to enhanced bacterial fitness. GlcNAc-1,6-anhydroMurNAc and peptide variants are transported by the essential major facilitator superfamily importer AmpG in Gram-negative pathogens including Escherichia coli, Klebsiella pneumoniae, Acinetobacter baumannii, and Pseudomonas aeruginosa. Accumulation of GlcNAc-1,6-anhydroMurNAc-pentapeptides also results from β-lactam antibiotic induced cell wall damage. In some species, these products upregulate the β-lactamase AmpC, which hydrolyzes β-lactams to allow for bacterial survival and drug-resistant infections. Here, we have used cryo-electron microscopy and chemical synthesis of substrates in an integrated structural, biochemical, and cellular analysis of AmpG. We show how AmpG accommodates the large GlcNAc-1,6-anhydroMurNAc peptides, including a unique hydrophobic vestibule to the substrate binding cavity, and characterize residues involved in binding that inform the mechanism of proton-mediated transport.
- 17 July 2024
- Published by Springer Nature in Nature
- Vol. 631 (8022) , 905-912
Tubulin code eraser CCP5 binds branch glutamates by substrate deformation
Microtubule function is modulated by the tubulin code, diverse posttranslational modifications that are altered dynamically by writer and eraser enzymes1. Glutamylation—the addition of branched (isopeptide-linked) glutamate chains—is the most evolutionarily widespread tubulin modification2. It is introduced by tubulin tyrosine ligase-like enzymes and erased by carboxypeptidases of the cytosolic carboxypeptidase (CCP) family1. Glutamylation homeostasis, achieved through the balance of writers and erasers, is critical for normal cell function3,4,5,6,7,8,9, and mutations in CCPs lead to human disease10,11,12,13. Here we report cryo-electron microscopy structures of the glutamylation eraser CCP5 in complex with the microtubule, and X-ray structures in complex with transition-state analogues. Combined with NMR analysis, these analyses show that CCP5 deforms the tubulin main chain into a unique turn that enables lock-and-key recognition of the branch glutamate in a cationic pocket that is unique to CCP family proteins. CCP5 binding of the sequences flanking the branch point primarily through peptide backbone atoms enables processing of diverse tubulin isotypes and non-tubulin substrates. Unexpectedly, CCP5 exhibits inefficient processing of an abundant β-tubulin isotype in the brain. This work provides an atomistic view into glutamate branch recognition and resolution, and sheds light on homeostasis of the tubulin glutamylation syntax.
- 17 July 2024
- Published by Springer Nature in Nature
- Vol. 631 (8022) , 905-912
Tubulin code eraser CCP5 binds branch glutamates by substrate deformation
Microtubule function is modulated by the tubulin code, diverse posttranslational modifications that are altered dynamically by writer and eraser enzymes1. Glutamylation—the addition of branched (isopeptide-linked) glutamate chains—is the most evolutionarily widespread tubulin modification2. It is introduced by tubulin tyrosine ligase-like enzymes and erased by carboxypeptidases of the cytosolic carboxypeptidase (CCP) family1. Glutamylation homeostasis, achieved through the balance of writers and erasers, is critical for normal cell function3,4,5,6,7,8,9, and mutations in CCPs lead to human disease10,11,12,13. Here we report cryo-electron microscopy structures of the glutamylation eraser CCP5 in complex with the microtubule, and X-ray structures in complex with transition-state analogues. Combined with NMR analysis, these analyses show that CCP5 deforms the tubulin main chain into a unique turn that enables lock-and-key recognition of the branch glutamate in a cationic pocket that is unique to CCP family proteins. CCP5 binding of the sequences flanking the branch point primarily through peptide backbone atoms enables processing of diverse tubulin isotypes and non-tubulin substrates. Unexpectedly, CCP5 exhibits inefficient processing of an abundant β-tubulin isotype in the brain. This work provides an atomistic view into glutamate branch recognition and resolution, and sheds light on homeostasis of the tubulin glutamylation syntax.
- Open Access
- 4 May 2023
- Published by Wiley in ChemBioChem
- Vol. 24 (11) , e202300205
Aldehyde‐Based Inhibitors of the Peptidoglycan O‐Acetylesterase Ape
The O‐acetylation of the muramic acid residues in peptidoglycan (PG) is a modification that protects the bacteria from lysis due to the action of lysozyme. In Gram‐negative bacteria, deacetylation is required to allow lytic transglycosylases to promote PG cleavage during cell growth and division. This deacetylation is catalyzed by O‐acetylpeptidoglycan esterase (Ape) which is a serine esterase and employs covalent catalysis via a serine‐linked acyl enzyme intermediate. Loss of Ape activity affects the size and shape of bacteria and dramatically reduces virulence. In this work, we report the first rationally designed aldehyde‐based inhibitors of Ape from Campylobacter jejuni. The most potent of these acts as a competitive inhibitor with a Ki value of 13 μM. We suspect that the inhibitors are forming adducts with the active site serine that closely mimic the tetrahedral intermediate of the normal catalytic cycle. Support for this notion is found in the observation that reduction of the aldehyde to an alcohol effectively abolishes the inhibition.
- 4 May 2023
- Published by Wiley in ChemBioChem
- Vol. 24 (11) , e202300205
Open AccessAldehyde‐Based Inhibitors of the Peptidoglycan O‐Acetylesterase Ape
The O‐acetylation of the muramic acid residues in peptidoglycan (PG) is a modification that protects the bacteria from lysis due to the action of lysozyme. In Gram‐negative bacteria, deacetylation is required to allow lytic transglycosylases to promote PG cleavage during cell growth and division. This deacetylation is catalyzed by O‐acetylpeptidoglycan esterase (Ape) which is a serine esterase and employs covalent catalysis via a serine‐linked acyl enzyme intermediate. Loss of Ape activity affects the size and shape of bacteria and dramatically reduces virulence. In this work, we report the first rationally designed aldehyde‐based inhibitors of Ape from Campylobacter jejuni. The most potent of these acts as a competitive inhibitor with a Ki value of 13 μM. We suspect that the inhibitors are forming adducts with the active site serine that closely mimic the tetrahedral intermediate of the normal catalytic cycle. Support for this notion is found in the observation that reduction of the aldehyde to an alcohol effectively abolishes the inhibition.
- 5 September 2022
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 75, 128971
A guanidinium group is an effective mimic of the tertiary carbocation formed by isopentenyl diphosphate isomerase
- 5 September 2022
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 75, 128971
A guanidinium group is an effective mimic of the tertiary carbocation formed by isopentenyl diphosphate isomerase
- 2 August 2022
- Published by Wiley in Chemistry – A European Journal
- Vol. 28 (43)
Frontispiece: Recent Advances in the Synthesis and Biological Applications of Peptidoglycan Fragments
- 2 August 2022
- Published by Wiley in Chemistry – A European Journal
- Vol. 28 (43)
Frontispiece: Recent Advances in the Synthesis and Biological Applications of Peptidoglycan Fragments
- 16 June 2022
- Published by Wiley in Chemistry – A European Journal
- Vol. 28 (43) , e202200788
Recent Advances in the Synthesis and Biological Applications of Peptidoglycan Fragments
The biosynthesis, breakdown, and modification of peptidoglycan (PG) play vital roles in both bacterial viability and in the response of human physiology to bacterial infection. Studies on PG biochemistry are hampered by the fact that PG is an inhomogeneous insoluble macromolecule. Chemical synthesis is therefore an important means to obtain PG fragments that may serve as enzyme substrates and elicitors of the human immune response. This review outlines the recent advances in the synthesis and biochemical studies of PG fragments, PG biosynthetic intermediates (such as Park's nucleotides and PG lipids), and PG breakdown products (such as muramyl dipeptides and anhydro‐muramic acid‐containing fragments). A rich variety of synthetic approaches has been applied to preparing such compounds since carbohydrate, peptide, and phospholipid chemical methodologies must all be applied.
- 16 June 2022
- Published by Wiley in Chemistry – A European Journal
- Vol. 28 (43) , e202200788
Recent Advances in the Synthesis and Biological Applications of Peptidoglycan Fragments
The biosynthesis, breakdown, and modification of peptidoglycan (PG) play vital roles in both bacterial viability and in the response of human physiology to bacterial infection. Studies on PG biochemistry are hampered by the fact that PG is an inhomogeneous insoluble macromolecule. Chemical synthesis is therefore an important means to obtain PG fragments that may serve as enzyme substrates and elicitors of the human immune response. This review outlines the recent advances in the synthesis and biochemical studies of PG fragments, PG biosynthetic intermediates (such as Park's nucleotides and PG lipids), and PG breakdown products (such as muramyl dipeptides and anhydro‐muramic acid‐containing fragments). A rich variety of synthetic approaches has been applied to preparing such compounds since carbohydrate, peptide, and phospholipid chemical methodologies must all be applied.
- 9 May 2022
- Published by Royal Society of Chemistry (RSC) in Chemical Communications
- Vol. 58 (45) , 6530-6533
Phosphinic acid-based inhibitors of tubulin polyglycylation
Phosphinic acid-based inhibitors of tubulin polyglycylation are identified.
- 9 May 2022
- Published by Royal Society of Chemistry (RSC) in Chemical Communications
- Vol. 58 (45) , 6530-6533
Phosphinic acid-based inhibitors of tubulin polyglycylation
Phosphinic acid-based inhibitors of tubulin polyglycylation are identified.
- Open Access
- 1 January 2021
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 296, 100528
Peptidoglycan binding by a pocket on the accessory NTF2-domain of Pgp2 directs helical cell shape of Campylobacter jejuni
- 1 January 2021
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 296, 100528
Open AccessPeptidoglycan binding by a pocket on the accessory NTF2-domain of Pgp2 directs helical cell shape of Campylobacter jejuni
- 1 November 2020
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 30 (22) , 127577
A guanidinium-based inhibitor of a type I isopentenyl diphosphate isomerase
- 1 November 2020
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 30 (22) , 127577
A guanidinium-based inhibitor of a type I isopentenyl diphosphate isomerase